Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 653589-95-8 | MDL No. : | MFCD05663866 |
Formula : | C14H19BO4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | GWSGJWIUSIAFOP-UHFFFAOYSA-N |
M.W : | 262.11 | Pubchem ID : | 2760076 |
Synonyms : |
|
Num. heavy atoms : | 19 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.5 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 74.2 |
TPSA : | 44.76 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.94 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 2.76 |
Log Po/w (WLOGP) : | 1.77 |
Log Po/w (MLOGP) : | 1.54 |
Log Po/w (SILICOS-IT) : | 1.77 |
Consensus Log Po/w : | 1.57 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.24 |
Solubility : | 0.151 mg/ml ; 0.000576 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.36 |
Solubility : | 0.116 mg/ml ; 0.000441 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.08 |
Solubility : | 0.022 mg/ml ; 0.0000839 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 3.05 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
86% | With palladium bis[bis(diphenylphosphino)ferrocene] dichloride; potassium acetate In 1,4-dioxane for 12 h; Inert atmosphere | Under nitrogen protection,Methyl o-bromobenzoate (2.15 g, 10 mmol),bis(pinacolato)diboron(3.05g, 12mmol),Potassium acetate (3.92 g, 40 mmol),[1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride (0.49 g, 0.5 mmol)It was added to 150 mL of dioxane and heated to 85 ° C for 12 hours.After the completion of the reaction, the dioxane was removed by distillation under reduced pressure, and the product was extracted with dichloromethane.Washed three times with saturated aqueous sodium chloride solution,After distilling off the dichloromethane under reduced pressure,The crude product was purified by column chromatography eluting with petroleum ether: methylene chloride = 3:1 (v/v) to give a solid, 2.25 g, yield 86percent.The results of 1H NMR, 13C NMR, MS and elemental analysis indicated that the obtained compound was the object product. |
84.9% | With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In toluene for 12 h; Inert atmosphere; Reflux | The dried 2 L reactor under nitrogen to 2-bromo-ethyl acetate 100 g (0.465 mol), bis(pinacolato)diboron 177.1 g (0.698 mol), [1,1 '- bis (diphenylphosphino) ferrocene ] dichloropalladium put 10.2 g (14 mmol), potassium acetate 136.9 g (1.395 mol) and 1000 mL of toluene was refluxed for 12 hours. Then filtered hot, the filtrate was concentrated under reduced pressure, and then separated by column chromatography to give the compound 96 g (yield: 84.9percent) represented by the [intermediate 7-c]. |
78.8% | With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In toluene for 12 h; Reflux | 2-bromoethyl acetate in 2L reactor 100 g (465 mmol), bis (pinacolato Collet Sat) dieboronic 177.1 g (698mmol), [1,1'- bis (diphenylphosphino) ferrocene]dichloropalladium 10.2 g put (14 mmol), potassium acetate 136.9 g (1395 mmol) and1000 mL of toluene was refluxed for 12 hours. Then filtered hot, the filtrate wasconcentrated under reduced pressure, and then separated by column chromatography togive the compound 96 g (yield: 78.8percent). |
62% | With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In toluene for 10 h; Reflux | Intermediate 1-d was synthesized according to Reaction Scheme 4 below.To a 500 mL round bottom flask reactor was added 2-bromo-methylbenzoate (14 g, 65 mmol), bispinacolatodiboron (10.4 g, 41 mmol), palladium (II) Diphenylphosphino) ferrocene (1.4 g, 1 mmol), potassium acetate (6.7 g, 68 mmol) and toluene (140 ml) were added and the mixture was refluxed with stirring for 10 hours. After completion of the reaction, the solid is filtered off and the filtrate is concentrated under reduced pressure. Separation by column chromatography gave intermediate 1-d. (10.5 g, 62percent). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
18% | With potassium acetate In N,N-dimethyl-formamide at 80℃; for 16 h; | In 5 mL of anhydrous DMF was added B3a (150 mg, 0.5 mmol), PdCl2dppf.CH2Cl2 (40 mg, 0.05 mmol), bis(pinacolato)diboron (190 mg, 0.75 mmol) and KOAc (147 mg, 1.5 mmol). The reaction was allowed to stir at 80° C. for 16 h. Upon cooling to room temperature, the reaction was filtered twice through celite and the resulting filtrate was concentrated and purified on a silica gel column eluting with 5percent EtOAc in hexanes yielding B3 in 18percent yield (24 mg, 0.09 mmol). 1H NMR (400 MHz, CDCl3) δ=7.93 (d, J=7.7 Hz, 1H), 7.50 (m, 2H), 7.40 (m, 1H), 3.91 (s, 3H), 1.42 (s, 12H). 13C NMR (100 MHz, CDCl3) δ=133.8, 133.0, 132.5, 129.2, 128.9, 128.5, 84.4, 74.3, 25.6. ESI-MS(+): m/z 262.88 [M+H]+. |
[ 269409-99-6 ]
Ethyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
Similarity: 0.97
[ 171364-80-0 ]
Methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
Similarity: 0.97
[ 480425-35-2 ]
Methyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
Similarity: 0.96
[ 944392-68-1 ]
Dimethyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isophthalate
Similarity: 0.96
[ 195062-62-5 ]
Ethyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
Similarity: 0.95
[ 269409-99-6 ]
Ethyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
Similarity: 0.97
[ 171364-80-0 ]
Methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
Similarity: 0.97
[ 480425-35-2 ]
Methyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
Similarity: 0.96
[ 944392-68-1 ]
Dimethyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isophthalate
Similarity: 0.96
[ 195062-62-5 ]
Ethyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
Similarity: 0.95
[ 269409-99-6 ]
Ethyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
Similarity: 0.97
[ 171364-80-0 ]
Methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
Similarity: 0.97
[ 480425-35-2 ]
Methyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
Similarity: 0.96
[ 944392-68-1 ]
Dimethyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isophthalate
Similarity: 0.96
[ 195062-62-5 ]
Ethyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
Similarity: 0.95